There is 1 version of this amendment. View text

Jump to: Description | Actions

Description

As of 03/23/2019 the description for this amendment has not been received.

Purpose:

An amendment numbered 3 printed in Part B of House Report 115-766 to direct the Commissioner of Food and Drugs to develop high-quality, evidence-based opioid analgesic prescribing guidelines for the indication-specific treatment of acute pain. In developing such guidelines, it requires the Commissioner of Food and Drugs to gather input through a public workshop and comment period, and to provide a report to Congress on how such guidelines will be used to protect the public health.

House Amendment Code:

(A003)

House Tally Clerks use this code to manage amendment information.


Actions (2)

Date All Actions
06/22/2018On agreeing to the Barton amendment (A003) Agreed to by voice vote.
06/22/2018Amendment (A003) offered by Mr. Barton. (consideration: CR H5562-5563; text: CR H5562-5563)